World ADC San Diego has been designed to dramatically enhance your ADC research and development efforts. Providing access to expert intelligence on how toselect your lead candidate with confidence, improve preclinical predictability and maximize clinical efficacy, the 2014 program cannot be missed.

This year, 65+ amazing speakers and over 550 of the global network of ADC developers will distill 12 months of learning into 4 jam packed days of insight and intelligence. Join us to improve your programs and be part of the mission to develop better ADC drugs.

Why should you attend this year:

• Genentech, ImmunoGen & Agensys reveal updates on leading clinical stage ADCs
• Improve linker components with insights on novel approaches from Synaffix, Sanofi & MedImmune
• Optimize the efficiency of preclinical development by learning from Takeda, UNC School of Pharmacy & Genentech
• Discover how novel targeting formats are helping Teva, Philogen & Merrimackenhance their ADC capabilities
• Improvements in up and downstream ADC processing and formulation will be revealed by Lonza, ImmunoGen & Baxter

If those have already whet your appetite, download the full agenda to read all about these presentations in more detail.